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Dose-Response Relationship of Bile Flow to Cholecystokinin
Stimulation as Measured by Duodenal Drainage
Robert J. Priest, M.D.;* Roberto F. Gluckmann, M.D.;*
J. Edward Berk, M.D,,** and Joseph A. Rinaldo, M.D.***

A study was done to evaluate the dose-response of cholecystokinin
administered
intravenously to normal patients and to patients with diseased gallbladders. The
volumes of bile and bilirubin units were measured in duodenal aspirates. A dosage
of cholecystokinin between 12.5 and 25 Ivy dog units differentiated the several
categories studied. Lower doses of cholecystokinin resulted in no change in the
volume of bile, but significantly reduced the output of bilirubin units.

smaller doses. The present study was
undertaken, therefore, to evaluate the
dose-response relationship of bile flow
as measured in duodenal drainage following the intravenous injection of
small doses of cholecystokinin.

In work reported earlier by us on
the use of cholecystokinin, 70 Ivy dog
units were given intravenously as the
stimulating dose.^ "' No important toxic
reactions were observed in approximately 500 patients to whom this dose
was administered. A transient sensation of facial heat sometimes accompanied by flushing was commonly experienced and occasionally, a generalized sensation of warmth occurred.
However, more serious reactions, such
as urticaria or hypotension, were not
noted.
Subsequent observations indicated
that such side effects which did occur
were markedly decreased when reduced
doses of cholecystokinin were injected
slowly. It was also noted that an adequate flow of bile for diagnostic biliary
drainage could be secured by using

Methods
A total of 217 patients was studied
comprising four separate groups: group
1, normal controls (81 subjects); group
2, patients with cholelithiasis whose
gallbladder visualized by oral cholangiography (42 patients); group 3, patients with cholelithiasis whose gallbladder failed to visualize (51 patients);
and group 4, patients who previously
had undergone surgical removal of the
gallbladder (43 patients). A double lumen tube was introduced in the duodenum and placed under fluoroscopic
observation so that the proximal lumen
drained the antrum of the stomach and
the distal lumen drained the duodenum
in the area of the ampulla of Vater.
Continuous gastric and duodenal aspi-
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cholecystokinin administration were
measured for volume and bilirubin content. The latter was expressed as "output of bilirubin units", a comparative
value described by Burton et al as the
volume of the sample in milliliters
multiplied by the icterus index of the
specimen determined by Meulengracht's method.^The aspirated duodenal contents
were centrifuged and the sediment examined under the microscope for
cholesterol crystals, calcium bilirubinate pigment, microspheroliths, and
parasites. As noted previously,-cholecystokinin stimulation provides a
sediment free of the confusing materials
found after such cholecystogogues as
olive oil and magnesium sulfate.
The several study groups were compared using the Krushal Wallis One
Way Analysis of Variance. The hypothesis tested by this method is that all
values come from the same overall
population. The data was evaluated at
the 5% level of significance. Results
are expressed as P. the probability that
all values come from the same population. If P is greater than 0.05, there
would be no reason to reject the assumption that aO values come from
the same population. If P equals or is
less than 0.05, the hypothesis that the
values come from the same population
is interpreted as without support. Using
median as the central value, the lower
and upper limits were expressed as
the 10th and 90th percentiles, respectively. When there were fewer than
nine patients in a group, however, the
next larger percentile was used.

ration was accomplished by pump suction at a fixed pressure. After a 10minute basal period, cholecystokinin
was given intravenously and was followed by collection of duodenal specimens at intervals of 10 minutes for one
hour.
The cholecystokinin used was supplied in dry form* containing 75 Ivy
dog units. An Ivy unit is that amount
of cholecystokinin which, dissolved
in normal saline solution, produces in
an anesthetized 15 Kg dog a rise in
intragallbladder pressure of one cm of
bile within three minutes after intravenous injection. Each 3 mg (75 Ivy
dog units) was known to contain other
gastrointestinal hormones, including 40
clinical units of secretin and 100 CrickHarper-Raper units of pancreozymin.
Jorpes has described how closely cholecystokinin and pancreozymin accompany each other during steps of purification. Cholecystokinin and pancreozymin are assumed to be the same homogeneous peptide of 33 amino acid
units."
Cholecystokinin was given intravenously in doses of 25, 18.5, 12.5,
and 7.5 units to each of the four
groups of subjects (Table I). Since
maximum contraction of the gallbladder in response to cholecystokinin has
Ivy Dog Units

25

18.5

12.5

1.5

Totals

Studv Group
Group 1. (Normal Subjects!

81

Group 2. (Gallstones Visualized)

42

Group 3. (Non-visualized Gallbladder)

51

Group 4. (Post-cholecystectomy)
Totals

43
44

66

53

54
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been found to occur within 20 minutes,"
the duodenal aspirates collected within the first 20 minutes after

Results
The volume and content of bilirubin
units of the duodenal aspirates obtained

' Vitrum—Stockholm
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Table II
Normal Subjects
7.5

Ivy Dog Units

25

18.5

12.5

Volume
(ml./20 min.

39 ^ 74

17 5i 76

15 ^ 93

Bilirubin Units

1,782 ^

15,589

1,340

18,392

496 ^

11,018

20^

184 ^

15,115

The underlined number in the middle represents the median.
The other numbers represent the 10th and 90th percentiles.

used for stimulation. In all categories
the evaluation of volume resulted in a
P value greater than 0.05.
The differences in the "output of
bilirubin units" among the diagnostic
categories when 18.5, 12.5 and 7.5
units of cholecystokinin were used to
stimulate secretion was statistically significant (Table IV). However, the P
value of 0.39 indicated no statistical
significance when 25 units of cholecystokinin was given.

from the group of normal subjects after
varying amount of cholecystokinin are
shown in Table I I . The differences
between the volume and bilirubin content of the duodenal aspirates were not
statistically significant, regardless of
the stimulating dose of cholecystokinin
used. The suggestion is obtained, however, that the values tend to be lower
with the smaller doses.
The volume differences among the
several study groups are shown in
Table I I I . These differences were not
found to be statistically significant, regardless of the dose of cholecystokinin

Discussion
Cholecystokinin induces relaxation

Table III
VOLUME
(ml./20 min.)
Normal

Gallstones
Visualized

Gallbladders
Non-visualized

Postcholecystectomy

"P"

25

29 ^ 74

18 ^ 122

51 ^ 243

40 ^ 110

0.17

18.5

17 59 76

19 ^ 92

25 ^ 72

14 ^ 83

0.43

12.5

15 ^ 93

33 ^ 83

13 ^ 107

6^61

0.50

7.5

20 ^ 89

37 52 92

22 ^ 133

13 22 63

0.089

Ivy Dog
Units

The underlined number in the middle represents the median.
The other numbers represent the 10th and 90th percentiles.
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Table IV
Output of Bilirubin Units
(First 20 Minutes)
Ivy Dog
Units

Normal

25

1,782 ^

15,589

18.5

1,340 ^

18,392

12.5
7.5

Gallstones
Visualized
412 5655
1,288

067
28,006

Non-visualized
Gallbladders
625 2iZ4ii,4oo

Postcholecystectomy

2,021 ^

13,568

,. p n

0.39

202 2512 5 984

352 I M 3 J39

0.001

486 ^ 1 1 , 0 1 8

320 3084 3 092

569 2280 12,530

178 i 2 M 2,511

0.05

184

868 2451 8,012

39 3 2110 5

138 ^

0.015

15,115

2,567

The underlined number in the middle represents the median.
The other numbers represent the 10th and 90th percentiles.

of the sphincter of Oddi and decrease
in tonus of the lower common bile duct
as well as evacuation of the gallbladder.'^ The fact that essentially
equal 20-minute volumes were obtained
in the normal subjects and in the postcholecystectomy patients we studied
suggests that the gallbladder contributes litde to the total volume of the
duodenal aspirate at these doses of
cholecystokinin. On the other hand,
subtraction of the median bilirubin content (Table IV) of the postcholecystectomy group from the normal control
group yields a value of about 3000
bilirubin units, regardless of the dose
of cholecystokinin used. Results of this
method for calculating bilirubin units
indicate that the gallbladder is contributing at least this amount to the
duodenal aspirate. In support of these
concepts, Edholm found that the average amount evacuated from the gallbladder was only 15 ml or 45% of
the initial volume (average 33 ml)
when 70 units of cholecystokinin were
used."^ An even smaller amount might
be anticipated from the doses used in

this study, especially since an intravenous injection of 25 Ivy dog units
in a normal person produces an average of only 40% emptying of the gallbladder,
Other possible influences that could
affect the volume of duodenal aspirate
are the flow of bile from the liver itself
and the flow of pancreatic juice. A l though Adlercreutz et al concluded
that cholecystokinin is not capable of
stimulating bile secretion from the
liver,!' Torsoli and associates'* provided data indicating that cholecystokinin has a choleretic effect. The
studies of Jonson et al^" with secretin
in dog preparations have suggested a
choleretic effect of purified secretin.
This choleretic action might increase
bile flow in patients with nonfunctioning gallbladders or in patients whose
gallbladder has been removed. The
secretin present in the cholecystokinin
preparation would certainly be expected to stimulate the flow of pancreatic juice.
Another variable is the possibility
of endogenous cholecystokinin in the
260
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blood of the patients tested. Caroli et al
have described a cholecystokinin inhibitor which is present normally and
in slight quantities even in cholecystectomized patients.^''
Apparently, normal subjects and
those with diseased gallbladders differ
in their degree of responsiveness to
cholecystogogues. Thus, stimulation of
a degree sufficient to cause evacuation
of the gallbladder in normal persons
may be ineffective in patients with
poorly functioning gallbladders. With
respect to cholecystokinin, the dose
that seems to accomplish this differentiation is greater than 12.5 but less
than 25 Ivy dog units. The fact that the
gallbladder response to 25 Ivy dog
units was not significantly different in
the various diagnostic categories we
studied suggests that large doses of
cholecystokinin stimulate diseased as
well as normal gaflbladders.
Summary
A study was made to test the doseresponse relationship of bile flow to
intravenously administered cholecystokinin as measured by duodenal drainage. Cholecystokinin was given for this
purpose in doses of 25, 18.5, 12.5 and

7.5 Ivy dog units.
Normal persons exhibited no significantly different response in 20-minute
volumes and 20-minute bilirubin concentrations of their duodenal aspirates
with each of the doses used. There
was a suggestion, however, that smaller
doses, especially 7.5 units, gave lower
values.
In patients with functioning gallbladders containing stones, or nonfunctioning gallbladders and in cholecystectomized patients, lowering the
cholecystokinin dosage resulted in no
significant change in the 20-minute
volume flow of bile. The output of
bilirubin units in the duodenal aspirates, however, was lowered significantly
by decreasing doses of cholecystokinin
in the range from 18.5 to 7.5 units.
The median output of bilirubin was
approximately 3000 units less than the
normal median at any dosage of cholecystokinin tested in the postcholecystectomized patients.
The dosage of cholecystokinin which
served to differentiate the bile flow
response to cholecystokinin in the several diagnostic categories was greater
than 12.5 but less than 25 Ivy dog
units.
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